Acute Abdomen in Chronic Renal Failure
0
Citation
5
Reference
10
Related Paper
Keywords:
Chronic renal failure
Nephrology
The prevalence of chronic kidney disease (CKD), especially the early stages, is still not exactly known. This is also true for CKD stage 3, when cardiovascular and other major complications generally appear. The NANHES data have shown a steady increase in the prevalence of CKD 3 up to 7.7% in 2004. Chronic kidney disease and renal failure are underdiagnosed all over the world. In Italy, prevalence estimates for stage 3 to 5 CKD are around 4 million yet, less than 30% of these subjects are believed to be followed at nephrology clinics. This means that in Italy for every dialyzed patient there are about 85 individuals with possibly progressive kidney disease, while fewer than five (mainly stage 4 and 5 patients) are actually followed by a nephrologist.
Nephrology
Chronic renal failure
Cite
Citations (179)
Chronic kidney disease (CKD) as defined by an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73 sq. m BSA affects about 20 million Americans. Existing CKD care models are predicated on Adult Primary Care referrals to Nephrology Clinics of patients with this arbitrary CKD staging criterion. Increasing referrals of CKD patients have far surpassed the capacity of Nephrology Clinics. Arguably, since most CKD patients remain stable over the years, Nephrology Clinic visits may represent expensive unnecessary care in the majority of referrals.
Nephrology
Cite
Citations (0)
The way nephrology develops in the new millennium is bound to be affected by changes in the nephrologist's clinical environment, as well as by the progress made in basic research which will need to find a clinical application. The nephrologist can expect to be more and more involved in renal substitution therapy, not just providing the treatment, but also managing the cost of the service. In the field of nephropathology, the highest expectations surround molecular biology and its application to both acquired and hereditary renal disease; the goal is to find an outlet for gene therapy in clinical practice. Artificial substitution therapy will focus chiefly on the project of 'intelligent dialysis', whereby biological and diagnostic components are combined according the specific needs of the individual patient. The ideal scenario for renal transplantation in the coming millennium would be one where donor supply matches the demand (xenotransplant?), where immunomodulation is perfected, and where diagnoses are based on precise biomolecular events observed in real time.
Nephrology
Renal replacement therapy
Cite
Citations (0)
Nephrology
Cite
Citations (0)
Several studies suggest improved outcomes for patients with kidney disease who consult a nephrologist. However, it remains undetermined whether a consultation with a nephrologist is related to a survival benefit after starting continuous renal replacement therapy (CRRT) due to acute kidney injury (AKI).Data from 2,397 patients who started CRRT due to severe AKI at Seoul National University Hospital, Korea between 2010 and 2020 were retrospectively collected. The patients were divided into two groups according to whether they underwent a nephrology consultation regarding the initiation and maintenance of CRRT. The Cox proportional hazards model was used to calculate the hazard ratio (HR) of mortality during admission to the intensive care unit after adjusting for multiple variables.A total of 2,153 patients (89.8%) were referred to nephrologists when starting CRRT. The patients who underwent a nephrology consultation had a lower mortality rate than those who did not have a consultation (HR = 0.47 [0.40-0.56]; P < 0.001). Subsequently, patients who had nephrology consultations were divided into two groups (i.e., early and late) according to the timing of the consultation. Both patients with early and late consultation had lower mortality rates than patients without consultations, with HRs of 0.45 (0.37-0.54) and 0.51 (0.42-0.61), respectively.Consultation with a nephrologist may contribute to a survival benefit after starting CRRT for AKI.
Nephrology
Renal replacement therapy
Cite
Citations (2)
Nephrology
Renal replacement therapy
Cite
Citations (0)
The cause of chronic kidney disease (CKD) cannot be ascertained in a substantial proportion of patients in developing countries. Whether there is a systematic difference between the characteristics of these patients and those with known causes of CKD is not known. We present differences in the baseline profile of subjects with CKD-cause unknown (CKD-CU) versus those with known causes of CKD who are enrolled in the ongoing, multicentric Indian Chronic Kidney Disease (ICKD) study in India.
Cite
Citations (0)
Cite
Citations (43)
Abstract Chronic kidney disease (CKD) represents a public health burden worldwide and is associated with significant morbidity and mortality. Most patients with CKD are managed by primary care practitioners and this educational series hope to improve knowledge and delivery of care to this high-risk patient population with CKD.
Nephrology
Prime time
Cite
Citations (3)
The prevalence of chronic kidney disease (CKD), especially the early stages, is still not exactly known. This is also true for CKD stage 3, when cardiovascular and other major complications generally appear. The NANHES data have shown a steady increase in the prevalence of CKD 3 up to 7.7% in 2004. Chronic kidney disease and renal failure are underdiagnosed all over the world. In Italy, prevalence estimates for stage 3 to 5 CKD are around 4 million yet, less than 30% of these subjects are believed to be followed at nephrology clinics. This means that in Italy for every dialyzed patient there are about 85 individuals with possibly progressive kidney disease, while fewer than five (mainly stage 4 and 5 patients) are actually followed by a nephrologist.
Nephrology
Chronic renal failure
Cite
Citations (4)